2354. Factors associated with COVID-19 booster vaccine hesitancy: a nation-wide, cross-sectional survey in Japan

2354. 影响新冠疫苗加强针接种犹豫的因素:一项日本全国性横断面调查

阅读:1

Abstract

BACKGROUND: COVID-19 vaccine hesitancy and/or fatigue is increasing as the pandemic enters the endemic phase. The present study aimed to explore current perceptions about COVID-19 booster vaccination among the Japanese public. METHODS: This cross-sectional study used data from the Japan COVID-19 and Society Internet Survey conducted in September 2021 and September 2022. The public’s perceptions of COVID-19 vaccination and factors associated with COVID-19 booster vaccine hesitancy were analyzed using multivariable logistic regression analysis. RESULTS: In total, 56,735 respondents were included. In the 2022 survey, 74.1% of the respondents (21,216/28,617) completed the primary series of vaccination with booster doses. Factors independently associated with booster vaccine hesitancy were young age (range: 18-29 years; adjusted odds ratio [aOR]: 6.56; 95% confidence interval [CI]: 5.07-8.47), history of COVID-19 (aOR: 1.82; 95% CI: 1.59-2.08), distrust of the Japanese government’s COVID-19 prevention measures (aOR: 1.55; 95% CI: 1.15-2.10), lack of confidence in COVID-19 vaccine efficacy (aOR: 1.30; 95% CI: 1.02-1.65), lack of confidence in COVID-19 vaccine safety (aOR: 1.62; 95% CI: 1.35-1.94), low reliance on the COVID-19 vaccine (aOR: 1.92; 95% CI: 1.35-2.73), and belief in COVID-19 conspiracy theories (aOR: 1.77; 95% CI: 1.17-2.67). Respondents’ selection [Figure: see text] Multivariate analysis of factors associated with COVID-19 booster vaccination hesitancy (n = 17,222) [Figure: see text] CONCLUSION: Providing clear and trustworthy information is critically important to promoting COVID-19 booster vaccination. Policymakers should therefore develop consistent and transparent communication strategies and the ability to respond promptly and flexibly to mitigate the negative impact of COVID-19 on the public while preparing for the next pandemic. DISCLOSURES: Hitoshi Honda, MD, Moderna: Honoraria

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。